Microneedle prototype combines invisible immunization record with vaccine
It’s a record that’s invisible to the naked eye, written in quantum dots that emit near-infrared light readable by a modified smartphone.
Related Articles
Which drugmakers will be hit hardest by the ‘One Big Beautiful Bill’?
Plus other biotech news stories of the day, brought to you by The Readout.
Federal judge tosses Blue Cross Blue Shield of Louisiana lawsuit, another loss for Medicare Advantage insurers
The Medicare Advantage industry has aggressively sued the federal government to overturn reduced quality ratings and keep billions of taxpayer-funded bonuses.
U.S. sees most single-year measles cases since it declared disease eliminated
The U.S. has now recorded more confirmed measles cases this year than in any year in well over a quarter-century.
Nearly 1 in 3 teens have prediabetes, CDC finds, in ‘wake-up call’
Nearly 1 in 3 American adolescents have prediabetes, a CDC report finds. An official notes “it’s not too late to change course.”
Use of antibiotic to reduce STIs appears to be fueling some antibiotic resistance, research shows
The use of the antibiotic doxycycline to reduce STIs appears to be fueling some antibiotic resistance, according to new research.
Justice Department issues subpoenas to clinics and drugmakers over gender-affirming care
A Justice Department official said it has issued “nearly 20 subpoenas” to clinics that provide gender-affirming care.
Mattel introduces its first Barbie with type 1 diabetes
Mattel has introduced its first Barbie representing a person with type 1 diabetes, as part of wider efforts from the toy maker to increase inclusivity…
HHS backtracks on pledge to disclose new vaccine advisers’ conflicts of interest
RFK Jr. has pledged radical transparency, but his vaccine advisers’ financial disclosures aren’t public.
Kennedy abruptly cancels preventative care committee meeting
HHS secretary Robert F. Kennedy Jr. has abruptly canceled a meeting of the USPSTF, an expert panel that evaluates the nation’s preventative care recommendations.
Merck to buy lung-disease biotech Verona Pharma for $10 billion
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss of revenue once Keytruda…